RA Capital Management, L.P. 13D and 13G filings for Relmada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
RA Capital Management, L.P. | 0 0.000% |
-2,000,000 (Position Closed) |
Filing |
| 2021-12-20 4:33 pm Purchase |
2021-12-09 | 13G | Relmada Therapeutics, Inc. RLMD |
RA Capital Management, L.P. | 2,000,000 7.200% |
2,000,000 (New Position) |
Filing |
| 2021-02-16 4:39 pm Sale |
2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
RA Capital Management, L.P. | 0 0.000% |
-761,666 (Position Closed) |
Filing |